new Delhi: Currently, at least seven Indian pharmaceutical companies Coronavirus Are busy preparing the vaccine for infection Efforts are being made to make vaccines to prevent the spread of this deadly epidemic globally. So far, 14 million people worldwide have been infected with this virus. So far, this epidemic has killed more than 6 lakh people globally.
Talking about domestic pharma companies, Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotech, Indian Immunologics, Maynavax and Biologics are trying to prepare the vaccine for Kovid-19.
However, making a vaccine or vaccine requires many years of testing and then additional time for production. But because of this epidemic, scientists are hoping to make a vaccine in a few months.
Bharat Biotech has been approved for the first and second phase clinical trials of the vaccine ‘Candidate’ Kovacine. It will be manufactured at the company’s Hyderabad factory. The company started human clinical trials last week.
Clinical trial expected to be completed in seven months
Another company, Serum Institute of India, hopes to produce the Kovid-19 vaccine by the end of this year.
“We are currently working on the AstraZeneca Oxford vaccine, which is undergoing Phase III clinical trials,” said Adar Poonawalla, Chief Executive Officer (CEO) of Serum Institute. We will start human trials in India in August 2020. Based on the information available regarding clinical trials so far, we hope that the AstraZeneca Oxford vaccine will be available by the end of this year.
Meanwhile, another pharma sector company, Zydus Cadila, said that it is hoping to complete clinical trials of vaccine ‘Candidate’ Zykov-D of Kovid-19 in seven months.
Zydus Cadila Chairman Pankaj R Patel said in a statement, “After the results of the study, if the data remains encouraging and the vaccine proves to be effective during the test, it will take seven months to complete the test and remove the vaccine.”
Hyderabad-based company Bharat Biotech started human vaccine testing of its vaccine covicin at the Institute of Medical Sciences, Rohtak last week. The Indian pharmaceutical regulator has received approval for the first and second phase clinical trials of the SARS-Cove-2 vaccine. The company developed the vaccine in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV).
Panacea Biotech said in June that it was setting up a joint venture in Ireland with Refena of the United States to develop the Kovid-19 vaccine.
Indian Immunologicals, a subsidiary of the National Dairy Development Board (NDDB), has tied up with Griffith University in Australia to develop the corona virus vaccine.
Apart from this, Maynavax and Biological E are also working to prepare the vaccine of Kovid-19.